Cell and gene therapy are novel therapeutics that have attracted much attention amongst the global biomedical sectors for the treatment of diseases and physiological conditions due to their promising potential in addressing unmet medical needs. Particularly, the unmet need for CGTs in Europe is significant.
Europe has a strong potential in the CGT industry growth from the drivers of robust cell & gene therapies in the pipeline, emerging numbers of CMOs offering vector manufacturing services for cell and gene therapy companies, increase in strategic acquisitions as well as regulatory support for cell and gene therapy products.
With the goal of enhancing Europe’s CGT R&D & manufacturing for a faster speed to market, the Cell & Gene Therapy World Summit 2024 brings Europe region’s CGT players together, to discuss and debate the best practices in CGT field while serve a platform to showcase your latest products and services to the cell and gene therapy industry leaders!
